Technical Analysis for AXSM - Axsome Therapeutics, Inc.

Grade Last Price % Change Price Change
D 89.24 2.28% 1.99
AXSM closed up 2.28 percent on Tuesday, November 5, 2024, on 64 percent of normal volume.
Earnings due: Nov 12
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Outside Day Range Expansion 0.00%
Fell Below 20 DMA Bearish 2.28%
MACD Bearish Centerline Cross Bearish 2.28%
Down 3 Days in a Row Weakness 2.28%
Down 4 Days in a Row Weakness 2.28%
50 DMA Resistance Bearish 0.45%
20 DMA Support Bullish 0.45%
Multiple of Ten Bearish Other 0.45%

   Recent Intraday Alerts

Alert Time
Up 2% about 9 hours ago
Rose Above Previous Day's High about 10 hours ago
Outside Day about 10 hours ago
Up 1% about 10 hours ago
60 Minute Opening Range Breakout about 13 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Organ Systems Clinical Development Alzheimer's Disease Chronic Pain Pain Management Depression Central Nervous System Disorders Nervous System Disorders Osteoarthritis Knee Chronic Condition Antidepressants Treatment Of Chronic Pain Back Pain Treatment Resistant Depression

Is AXSM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 98.4
52 Week Low 55.0276
Average Volume 405,065
200-Day Moving Average 82.47
50-Day Moving Average 90.18
20-Day Moving Average 89.09
10-Day Moving Average 89.53
Average True Range 2.97
RSI (14) 49.49
ADX 10.29
+DI 20.33
-DI 23.42
Chandelier Exit (Long, 3 ATRs) 86.08
Chandelier Exit (Short, 3 ATRs) 89.75
Upper Bollinger Bands 94.75
Lower Bollinger Band 83.42
Percent B (%b) 0.51
BandWidth 12.72
MACD Line -0.11
MACD Signal Line 0.06
MACD Histogram -0.1794
Fundamentals Value
Market Cap 4.22 Billion
Num Shares 47.3 Million
EPS -4.57
Price-to-Earnings (P/E) Ratio -19.53
Price-to-Sales 20.74
Price-to-Book 17.03
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 94.28
Resistance 3 (R3) 93.78 91.60 93.44
Resistance 2 (R2) 91.60 90.32 91.85 93.16
Resistance 1 (R1) 90.42 89.52 91.01 90.92 92.88
Pivot Point 88.24 88.24 88.54 88.49 88.24
Support 1 (S1) 87.06 86.96 87.65 87.56 85.60
Support 2 (S2) 84.88 86.16 85.13 85.32
Support 3 (S3) 83.70 84.88 85.04
Support 4 (S4) 84.20